Clinical Trial Update: Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a [NA]

View source ↗

Summary

Clinical trial update on genomic-targeted chemoprevention for prostate cancer, completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Endeavor Health | Conditions: Prostate Cancer, Prostate Cancer, Familial | NA | Status: COMPLETED | Results posted: 2019-11-22